Introduction: Myelomeningocele (MMC) is a congenital central nervous system malformation caused by a failure of the neurulation process in early pregnancy. Patients with MMC present many abnormalities and the nervous, skeletal and urinary systems are the most affected. The aim of this study was to clinically evaluate patients with MMC, estimate renal and lower urinary tract (LUT) function and to ascertain whether urodynamic findings can predict the deterioration of urinary tract function. Materials and Methods: Medical records of 112 patients were gathered from a database and evaluated retrospectively. The data included age, sex, BMI Z-score WHO, physical activity, urodynamic parameters and diagnosis and renal function. Results: A total of 112 patients with MMC were enrolled in the study. There were no differences in age, sex, BMI Z-score WHO, physical activity, renal function and urodynamic findings (apart from cystometric capacity) between boys and girls. Detrusor overactivity was the most frequent urodynamic diagnosis in all groups of physical activity, level of lesion and in catheterized and non-catheterized children. The correlations between urodynamic findings and renal function tests were found. Conclusions: Patients with neurogenic bladder after MMC most often present detrusor overactivity. LUT function is disturbed in all MMC patients independent of lesion level and physical activity.

Keywords:
Urodynamics, Uroflowmetry, Cystometry, Meningomyelocele, Neurogenic bladder
1.
Chang CK, Wong TT, Huang BS, Chan RC, Yang TF: Spinal dysraphism: a cross-sectional and retrospective multidisciplinary clinic-based study. J Chin Med Assoc 2008;71:502-508.
2.
Verhoef M, Lurvink M, Barf HA, et al: High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord 2005;43:331-340.
3.
Schwerdtfeger WI, Steudel T, Pitzen AEM: Mautes: spinal injury epidemiology, management, therapy and prognosis. Intensive Care Med 2004;41:71-80.
4.
Esposito C, Guys JM, Gough D, Savanelli A (eds): Pediatric Neurogenic Bladder Dysfunction. Diagnosis, Treatment, Long-Term Follow-Up. Springer, 2006.
5.
Northrup H, Volcik KA: Spina bifida and other neural tube defects. Curr Probl Pediatr 2000;30:313-332.
6.
Morris MS, Jacques PF, Rosenberg IH, Selhub J: Hyperhomocysteinemia associated with poor recall in the third national health and nutrition examination survey. Am J Clin Nutr 2001;73:927-933.
7.
Czeizel AE: Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179-183.
8.
Liao L: A new comprehensive classification system for both lower and upper urinary tract dysfunction in patients with neurogenic bladder. Urol Int 2015;94:244-248.
9.
Van Gool JD: Vesico-ureteral reflux in children with spina bifida and detrusor-sphincter dyssynergia. Contrib Nephrol 1984;39:221-237.
10.
Glott T, Stanghelle JK, Rand-Hendriksen S, Thyberg M, Melhus M, Brabrand K, et al: [Follow up of urinary tract problems in adults with myelomeningocele]. Tidsskr Nor Laegeforen 2001;121:1247-1251.
11.
Singhal B, Mathew KM: Factors affecting mortality and morbidity in adult spina bifida. Eur J Pediatr Surg 1999;9(suppl 1):31-32.
12.
Greig JD, Young DG, Azmy AF: Follow-up of spina bifida children with and without upper renal tract changes at birth. Eur J Pediatr Surg 1991;1:5-9.
13.
Muralikrishna GS, Rodger RS, Macdougall AI, Boulton-Jones JM, Allison ME, Kyle KF, Junor BJ, Briggs JD: Renal replacement treatment in patients with spina bifida or spinal cord injury. BMJ 1989;299:1506.
14.
Woodhouse CR: Progress in the management of children born with spina bifida. Eur Urol 2006;49:777-778.
15.
Wide P, Glad Mattsson G, Mattsson S: Renal preservation in children with neurogenic bladder-sphincter dysfunction followed in a national program. J Pediatr Urol 2012;8:187-193.
16.
De Jong TP, Chrzan R, Klijn AJ, Dik P: Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol 2008,23:889-896.
17.
Filler G, Gharib M, Casier S, Lödige P, Ehrich JH, Dave S: Prevention of chronic kidney disease in spina bifida. Int Urol Nephrol 2012;44:817-827.
18.
Dik P, Klijn AJ, van Gool JD, de Jong-de Vos van Steenwijk CC, de Jong TP: Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 2006:49:908-913.
19.
Olsson I, Dahl M, Mattsson S, Wendelius M, Aström E, Westbom L: Medical problems in adolescents with myelomeningocele (MMC): an inventory of the Swedish MMC population born during 1986-1989. Acta Paediatr 2007;96:446-449.
20.
Hoffer MM, Feiwell E, Perry R, Perry J, Bonnett C: Functional ambulation in patients with myelomeningocele. J Bone Joint Surg Am 1973;55:137-148.
21.
Counahan R, Chantler C, Ghazali S, et al: Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 1976:51:875-878.
22.
Vora JP, Dolben J, Dean JD, et al: Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992;41:829-835.
23.
Roach JW, Short BF, Saltzman HM: Adult consequences of spina bifida: a cohort study. Clin Orthop Relat Res 2011;469:1246-1252.
24.
Vírseda MC, Salinas JC, Bolufer E, Esteban MF: Endoscopic treatment of vesicoureteral reflux with non-simultaneous involuntary detrusor contraction in chronic spinal cord injury patients with neurogenic detrusor overactivity. Urol Int 2014;93:399-402.
25.
Park M, Yoon E, Lim YH, Kim H, Choi J, Yoon HJ: Renal hyperfiltration as a novel marker of all-cause mortality. J Am Soc Nephrol 2014;pii:ASN 2014010115.
26.
Ulsenheimer MM, Antoniuk SA, Santos LH, Ceccatto MP, Silveira AE, Ruiz AP, Egger P, Bruck I: Myelomeningocele: a Brazilian University Hospital experience. Arq Neuropsiquiatr 2004;62:963-968.
27.
Kessler TM, Lackner J, Kiss G, Rehder P, Madersbacher H: Predictive value of initial urodynamic pattern on urinary continence in patients with myelomeningocele. Neurourol Urodyn 2006;4:361-367.
28.
Akbar M, Bresch B, Raiss P, Fürstenberg CH, Bruckner T, Seyler T, Carstens C, Abel R: Fractures in myelomeningocele. J Orthop Traumatol 2010;11:175-182.
29.
Müller T, Arbeiter K, Aufricht C: Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol 2002;12:479-484.
30.
Olandoski KP, Koch V, Trigo-Rocha FE: Renal function in children with congenital neurogenic bladder. Clinics (Sao Paulo) 2011;66:189-195.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.